Jul 31, 2021

Featuring an interview with Dr Kristen Ciombor, including the following topics:

• Final overall survival from the Phase III KN177 study evaluating pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer (mCRC) (0:00)
• Trastuzumab deruxtecan (T-DXd) in...

Jul 23, 2021

Featuring an interview with Dr Sara M Tolaney, including the following topics:

• Role of the Breast Cancer Index® in predicting benefit from extended aromatase inhibitor therapy for hormone receptor (HR)-positive breast cancer  (0:00)
• ADAPT HR-positive/HER2-negative trial: Prognostic utility of genomic assays, clinical...

Jul 22, 2021

Featuring an interview with Dr Jaffer Ajani, including the following topics:

• Evolving Therapeutic Landscape of Upper Gastrointestinal Tumors (0:00)
• Case: A Man in His Late 50s with PD-L1-Positive, HER2-Negative, Microsatellite-Stable Metastatic Adenocarcinoma of the Gastroesophageal Junction (29:01)
• Case: A Man in His...

Jul 20, 2021

Proceedings from a daylong multitumor educational webinar in partnership with the Texas Society of Clinical Oncology, featuring key clinical presentations and papers in breast cancer. Featuring perspectives from Drs Virginia F Borges and Harold J Burstein, including the following topics:

• Introduction 
• Cases from the...

Jul 20, 2021

Proceedings from a daylong multitumor educational webinar in partnership with the Texas Society of Clinical Oncology, featuring key clinical presentations and papers in gynecologic cancers. Featuring perspectives from Drs Deborah K Armstrong and Krishnansu S Tewari, including the following topics:

• Introduction 
• Cases...